Prescription drug · NDA
Doryx Mpc (Doxycycline hyclate) NDC 51862-560
Doxycycline hyclate 60 mg/1 · Tablet, Delayed release · Oral · Mayne Pharma Commercial LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51862-560-00 | 5186205600051862056000 | 1 BOTTLE in 1 CARTON (51862-560-00) / 6 TABLET, DELAYED RELEASE in 1 BOTTLEMarketed from Jan 2, 2023 | |
| 51862-560-60 | 5186205606051862056060 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (51862-560-60)Marketed from May 13, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doryx Mpc
- Generic name (nonproprietary)
- doxycycline hyclate
- Active ingredients
- Doxycycline hyclate — 60 mg/1
- Dosage form
- Tablet, Delayed release
- Route
- Oral
- Labeler
- Mayne Pharma Commercial LLCNDC labeler code 51862
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 050795
- Marketing start
- Listing expires
- Other FDA classes
- Tetracyclines (Chemical structure)
- Identifiers
- Product ID 51862-560_4af31df5-71da-3b6f-e063-6294a90a3906SPL ID 4af31df5-71da-3b6f-e063-6294a90a3906SPL set ID f9277bb8-982d-444d-9325-35d5c53a2d35RxCUI 1801138, 1801140, 1801142, 1801144UNII 19XTS3T51U
- Pharmacologic class
- Tetracycline-class Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451862056000followed by a unit qualifier and the quantityPackage 51862-0560-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
DORYX MPC is a tetracycline class drug indicated for: Rickettsial Infections ( 1.1 ) Sexually Transmitted Infections ( 1.2 ) Respiratory Tract Infections( 1.3 ) Specific Bacterial Infections ( 1.4 ) Ophthalmic Infections ( 1.5 ) Anthrax, Including Inhalational Anthrax (Post-Exposure) ( 1.6 ) Alternative Treatment for Selected Infections when Penicillin is Contraindicated ( 1.7 ) Adjunctive Therapy in Acute Intestinal Amebiasis and Severe Acne ( 1.8 ) Prophylaxis of Malaria ( 1.9 ) Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate and other antibacterial drugs, DORYX MPC Tablets should be used only to treat or prevent infections t…
Excerpt only. Read the full label for complete information.
About NDC 51862-560
- What is NDC 51862-560?
- 51862-560 is the product NDC for Doryx Mpc (doxycycline hyclate), Doxycycline hyclate 60 mg/1 tablet, delayed release, listed with the FDA by Mayne Pharma Commercial LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Doryx Mpc (Doxycycline hyclate).
- What is the active ingredient?
- Doxycycline hyclate.
- Who is the labeler?
- Mayne Pharma Commercial LLC, NDC labeler code 51862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Doryx Mpc?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 050795
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxycycline Hyclate | Doxycycline hyclate 200 mg/1 | Tablet, Delayed releaseOral | Mayne Pharma Commercial LLC | 68308-716 |